The world’s first industrial-scale manufacturing facility for radiolabelled peptides used in nuclear medicine has been approved by the Italian Pharmaceutical …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

